Similarly, the glycoprotein fibulin-4 plays both pro-oncogenic and anti-oncogenic roles, as a higher expression of fibulin-4 leads to tumor progression in cervical, glioblastoma, and ovarian carcinoma, and a decreased expression leads to a poor prognosis of endometrial cancer [69]. Here, EFEMP2 is linked to ovarian carcinoma.